259 related articles for article (PubMed ID: 33183733)
61. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
62. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
63. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors.
Rodriguez A; Kamiya-Matsuoka C; Majd NK
Curr Oncol; 2023 May; 30(6):5279-5298. PubMed ID: 37366884
[TBL] [Abstract][Full Text] [Related]
64. Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted Therapeutics.
Kram DE; Henderson JJ; Baig M; Chakraborty D; Gardner MA; Biswas S; Khatua S
Bioengineering (Basel); 2018 Sep; 5(4):. PubMed ID: 30249036
[TBL] [Abstract][Full Text] [Related]
65. Imaging characteristics of atypical teratoid-rhabdoid tumor in children compared with medulloblastoma.
Koral K; Gargan L; Bowers DC; Gimi B; Timmons CF; Weprin B; Rollins NK
AJR Am J Roentgenol; 2008 Mar; 190(3):809-14. PubMed ID: 18287456
[TBL] [Abstract][Full Text] [Related]
66. Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem.
Rubinstein LJ
J Neurosurg; 1985 Jun; 62(6):795-805. PubMed ID: 2987439
[TBL] [Abstract][Full Text] [Related]
67. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
[TBL] [Abstract][Full Text] [Related]
68. "Polyphenotypic" tumors in the central nervous system: problems in nosology and classification.
Jay V; Edwards V; Halliday W; Rutka J; Lau R
Pediatr Pathol Lab Med; 1997; 17(3):369-89. PubMed ID: 9185218
[TBL] [Abstract][Full Text] [Related]
69. Pediatric central nervous system tumors.
Reddy AT; Packer RJ
Curr Opin Oncol; 1998 May; 10(3):186-93. PubMed ID: 9619353
[TBL] [Abstract][Full Text] [Related]
70. [Update on the 2016 WHO classification of tumors of the central nervous system.Part 2: Embryonal tumors and other tumor groups (except for diffuse gliomas)].
Zámečník J; Rychlý B; Švajdler M
Cesk Patol; 2017; 53(1):22-28. PubMed ID: 28248118
[TBL] [Abstract][Full Text] [Related]
71. Significance and therapeutic value of miRNAs in embryonal neural tumors.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Molecules; 2014 May; 19(5):5821-62. PubMed ID: 24806581
[TBL] [Abstract][Full Text] [Related]
72. Rhabdoid tumor: the Irish experience 1986-2013.
Uwineza A; Gill H; Buckley P; Owens C; Capra M; O'Sullivan C; McDermott M; Brett F; Farrell M; Pears J; O'Sullivan MJ
Cancer Genet; 2014 Sep; 207(9):398-402. PubMed ID: 25085603
[TBL] [Abstract][Full Text] [Related]
73. Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems.
Vogel H; Fuller GN
Ann Diagn Pathol; 2003 Dec; 7(6):387-98. PubMed ID: 15018124
[TBL] [Abstract][Full Text] [Related]
74. Atypical teratoid/rhabdoid tumor in the sella turcica of an elderly female with a distinct vascular pattern and genetic alterations.
Nobusawa S; Nakata S; Hirato J; Kawashima T; Sato K; Fujimaki H; Okura N; Ikota H; Yokoo H
Virchows Arch; 2016 Dec; 469(6):711-715. PubMed ID: 27595781
[No Abstract] [Full Text] [Related]
75. Embryonal brain tumor with unknown primary lesion and massive cerebrospinal fluid dissemination: A case report.
Tanaka H; Yamamoto D; Ikeda M; Morikawa M; Ueda K; Tanaka K; Sasayama T; Kohmura E
J Clin Neurosci; 2018 Aug; 54():125-128. PubMed ID: 29843922
[TBL] [Abstract][Full Text] [Related]
76. Efficacy and safety of bevacizumab, irinotecan, and temozolomide combination for relapsed or refractory pediatric central nervous system embryonal tumor: a single-institution study.
Shiba Y; Motomura K; Taniguchi R; Kurimoto M; Mizutani K; Ohka F; Aoki K; Ito E; Nishikawa T; Yamaguchi J; Kibe Y; Shimizu H; Maeda S; Nakashima T; Suzuki H; Muramatsu H; Takahashi Y; Saito R
J Neurosurg Pediatr; 2023 Mar; ():1-9. PubMed ID: 36905668
[TBL] [Abstract][Full Text] [Related]
77. Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC).
Story E; Johnston DL; Bartels U; Carret AS; Crooks B; Eisenstat DD; Fryer C; Lafay-Cousin L; Larouche V; Wilson B; Zelcer S; Silva M; Brossard J; Bouffet E; Keene DL
J Neurooncol; 2017 Jul; 133(3):581-587. PubMed ID: 28508928
[TBL] [Abstract][Full Text] [Related]
78. Late-onset Hemorrhagic Disease of a Newborn Mimicjing an Atypical Teratoid/Rhabdoid Tumor.
Kamate M; Detroja M; Hattiholi V
Neurol India; 2019; 67(6):1566-1567. PubMed ID: 31857566
[No Abstract] [Full Text] [Related]
79. Embryonal tumor with multilayered rosettes,
Tauziède-Espariat A; Dufour C; Zerah M; Gareton A; Dangouloff-Ros V; Lechapt E; Boddaert N; Varlet P
Clin Neuropathol; 2021; 40(1):11-16. PubMed ID: 32831158
[TBL] [Abstract][Full Text] [Related]
80. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
